GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
7T9J | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 Omicron spike protein | |
7T9K | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 | |
7T9K | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 | |
7T9L | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
7T9L | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
7T9M | 7T9M | Human Thyrotropin receptor bound by CS-17 Inverse Agonist Fab/Org 274179-0 Antagonist | |
7T9M | A0A0A0MTJ0 | Human Thyrotropin receptor bound by CS-17 Inverse Agonist Fab/Org 274179-0 Antagonist | |
7T9N | 7T9N | M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure) | |
7T9N | A0A0A0MTJ0 | M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure) | |
7T9N | P63092 | M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure) | |
7T9N | P62873 | M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure) | |
7T9N | P59768 | M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure) | |
7T9T | M4M0W3 | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with complex glycans | |
7T9T | Q2N0S5 | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with complex glycans | |
7T9T | 7T9T | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with complex glycans | |
7TAA | P10529 | FAMILY 13 ALPHA AMYLASE IN COMPLEX WITH ACARBOSE | TAKA AMYLASE |
7TAS | P0DTC2 | SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146) | |
7TAS | 7TAS | SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146) | |
7TAT | P0DTC2 | SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open) | |
7TAT | 7TAT | SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open) | |
7TB4 | A0A8A4XEV3 | Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern | |
7TB8 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 | |
7TB8 | 7TB8 | Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 | |
7TBB | Q2KNW6 | Crystal structure of Plasmepsin X from Plasmodium falciparum | |
7TBC | Q2KNW6 | Crystal structure of Plasmepsin X from Plasmodium falciparum in complex with WM382 | |
7TBD | A0A1G4H6I9 | Crystal structure of Plasmepsin X from Plasmodium vivax in complex with WM382 | |
7TBE | A0A1G4H6I9 | Crystal structure of Plasmepsin X from Plasmodium vivax in complex with WM4 | |
7TBF | P0DTC2 | Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 | |
7TBF | 7TBF | Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 | |
7TBW | B2RUU2 | The structure of ATP-bound ABCA1 | |
7TBY | B2RUU2 | The structure of human ABCA1 in nanodisc | |
7TBZ | B2RUU2 | The structure of ABCA1 Y482C | |
7TC0 | B2RUU2 | The structure of human ABCA1 in digitonin | |
7TC9 | P0DTC2 | Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1 | |
7TC9 | 7TC9 | Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1 | |
7TCA | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1 | |
7TCA | 7TCA | Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1 | |
7TCC | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1 | |
7TCC | 7TCC | Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1 | |
7TCE | Q02761 | Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone. | |
7TCE | A3PFR5 | Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone. | |
7TCE | Q02762 | Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone. | |
7TCN | M4M0W3 | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-mannose glycans | |
7TCN | Q2N0S5 | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-mannose glycans | |
7TCN | 7TCN | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-mannose glycans | |
7TCO | M4M0W3 | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.G458Y.SOSIP.664 with high-mannose glycans | |
7TCO | Q2N0S5 | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.G458Y.SOSIP.664 with high-mannose glycans | |
7TCO | 7TCO | Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.G458Y.SOSIP.664 with high-mannose glycans | |
7TCT | P08514 | Integrin alaphIIBbeta3 complex with UR2922 | |
7TCT | P05106 | Integrin alaphIIBbeta3 complex with UR2922 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024